Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploidentical/matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Transfusion-dependent Thalassemia
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(5 sites)
China
Maoming People's Hospital, Maoming, Guangdong
Liuzhou Workers' Hospital, Liuchow, Guangxi
The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi